FDA inspection
Aurobindo Pharma Limited: FDA inspection ending Sep 5, 2025
FDA inspection 1286862 · Official Action Indicated (OAI) · Medchal
Key facts
| Inspection ID | 1286862 |
|---|---|
| Firm | Aurobindo Pharma Limited |
| FEI number | 3004446312 |
| Address | Unit Xii, 314 Survey No |
| City | Medchal |
| Country | India |
| Fiscal year | 2025 |
| Inspection end date | Sep 5, 2025 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data